| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,062,790 | 1,125,645 | 1,018,746 | 1,100,668 | 1,093,183 |
| Cost of Revenue
|
-650,244 | -684,338 | -588,885 | -645,285 | -604,722 |
|
Gross Profit
|
412,546 | 441,307 | 429,861 | 455,383 | 488,461 |
| Selling, General and Administrative Expenses
|
-144,489 | -147,801 | -133,586 | -170,577 | -139,349 |
|
Research and Development Expenses
|
-561,076 | -542,380 | -419,210 | -384,216 | -335,246 |
|
Operating Income/Expenses
|
-705,565 | -690,181 | -552,796 | -554,793 | -474,595 |
|
Total Operating Profit/Loss
|
-293,019 | -248,874 | -122,935 | -99,410 | 13,866 |
| Total Net Finance Income/Expense
|
19,865 | 19,707 | 22,931 | 22,190 | 3,475 |
|
Other Income/Expense, Non-Operating
|
113,191 | 53,254 | 61,091 | 12,722 | 52,299 |
|
Non-Operating Income/Expenses, Total
|
133,056 | 72,961 | 84,022 | 34,912 | 55,774 |
|
Pretax Income
|
-159,963 | -175,913 | -38,913 | -64,498 | 69,640 |
|
Provision for Income Tax
|
-- | -- | -- | -- | 0 |
|
Net Income from Continuing Operations
|
-159,963 | -175,913 | -38,913 | -64,498 | 69,640 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-159,963 | -175,913 | -38,913 | -64,498 | 69,640 |
|
Non-Controlling/Minority Interests
|
-- | -- | -- | -- | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
-159,963 | -175,913 | -38,913 | -64,498 | 69,640 |
|
Net Income Available to Common Stockholders
|
-159,963 | -175,913 | -38,913 | -64,498 | 69,640 |
|
Diluted Net Income Available to Common Stockholders
|
-159,963 | -175,913 | -38,913 | -64,498 | 69,640 |
| Basic EPS
|
-1.62 | -1.83 | -0.41 | -0.68 | 0.80 |
| Diluted EPS
|
-1.62 | -1.83 | -0.41 | -0.68 | 0.79 |
|
Basic Weighted Average Shares Outstanding
|
97,755.01 | 96,127.32 | 94,909.76 | 94,850 | 87,050 |
|
Diluted Weighted Average Shares Outstanding
|
97,755.01 | 96,127.32 | 94,909.76 | 94,850 | 88,151.90 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-179,828 | -195,620 | -61,844 | -86,688 | 66,165 |
|
EBITDA
|
-6,981 | -54,377 | 19,609 | -22,086 | 116,867 |
|
Normalized EBITDA
|
-11,042 | -55,601 | 21,050 | 6,495 | 134,761 |
|
Normalized Income
|
-164,024 | -177,137 | -37,472 | -35,917 | 83,955.20 |
|
Total Unusual Items
|
-4,061 | -1,224 | 1,441 | 28,581 | 17,894 |
|
Total Unusual Items Excluding Goodwill
|
-4,061 | -1,224 | 1,441 | 28,581 | 17,894 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 3,578.80 |
12/31/2022 - 12/28/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade